Interactive paper · systematic review · Acta Neurochirurgica · 2026

Surgical corridors to the infratemporal fossa

Andrei Cristian Albu · Bogdan Vintilă · Mugurel Constantin Rusu
DOI 10.1007/s00701-026-07049-1 · Published 30 September 2026 · Open access (CC BY 4.0)
Clinical-anatomical question

Which corridor reaches which part of the infratemporal fossa, and at what cost?

The review does not identify a universal “best” route. Its central synthesis is target-driven: endonasal and transoral corridors favour medial and inferomedial targets; transorbital access adds a superolateral line of sight; lateral and transcranial routes provide broader posterior and vascular control; combined multiportal strategies can approach whole-fossa coverage.

29studies included
6corridor families
4bibliographic databases
57–88%reported GTR/NTR range; not comparable across corridors
V2/V3trigeminal dysfunction was the most frequent neural morbidity
Interactive synthesis

Corridor-to-subregion exposure matrix

Choose a corridor family or click its row. Green = well exposed/primary target; half amber = partial, extension or adjunct; open grey = poorly reached/not targeted. These are qualitative evidence mappings, not pooled effect sizes.

Published quantitative examples

What the anatomical studies actually measured

8.46 ± 1.56 cm²

Endoscopic Denker exposure

Largest area among the staged endonasal steps in the cited incremental-maxillectomy study.

8.75 ± 1.40 cm²

Combined multiportal PPF area

Versus 4.40 ± 0.86 cm² for isolated EETA in the cited multiportal cadaveric study (p<0.001).

731 ± 80 mm²

Transorbital middle-cranial-fossa area

Versus 468 ± 60 mm² for Caldwell–Luc and 267 ± 47 mm² for contralateral endonasal access in the cited comparison.

92% ↔ 78.7%

Anterior ITF resection volume

Subtemporal versus endonasal in one comparative study; the same study favoured endonasal access for PPF clearance (100% vs 73.1%).

Do not turn these numbers into a league table. Targets, pathology, specimen design, metrics and units differed enough that the review explicitly rejected meta-analytic pooling and cross-corridor efficacy ranking.
Review architecture

Systematic, appraised, but deliberately not pooled

PRISMA 2020

Systematic review with structured narrative synthesis.

20 Jan 2026

Search through PubMed/MEDLINE, Scopus, Embase and Web of Science, plus reference lists.

2 reviewers

Independent screening, full-text assessment and item-level appraisal.

QUACS + JBI

Cadaveric/radio-anatomical studies appraised with QUACS; clinical series/case reports with JBI tools.

The search identified 887 database records plus 24 hand-searched records. After deduplication, 743 records were screened, 86 full texts were assessed, and 29 studies were included.

Interpretive boundary

Anatomical feasibility is not clinical efficacy

What the evidence supports

Comparative anatomy can show line of sight, working depth, surgical freedom, exposed area and the structures placed at risk. It can clarify which corridor is mechanically suited to a defined subregion.

What it cannot establish

A larger cadaveric exposure does not prove better tumour control or lower morbidity. Clinical series were small, retrospective, single-centre and heterogeneous in pathology and follow-up.

Practical synthesis: medial/paramedian disease generally aligns with endonasal access; inferomedial/parapharyngeal targets may favour transoral access; superolateral disease may require transorbital reach; posterior, vascular-encasing or invasive disease often requires lateral/transcranial or combined routes. The target, vascular relationships and required margins determine the route.